PMID- 37794445 OWN - NLM STAT- MEDLINE DCOM- 20231006 LR - 20231121 IS - 1757-1146 (Electronic) IS - 1757-1146 (Linking) VI - 16 IP - 1 DP - 2023 Oct 5 TI - Association between triglyceride glucose index and severity of diabetic foot ulcers in type 2 diabetes mellitus. PG - 68 LID - 10.1186/s13047-023-00663-7 [doi] LID - 68 AB - BACKGROUND: Triglyceride glucose (TyG) index is a good surrogate biomarker to evaluate insulin resistance (IR). The study aimed to investigate whether the TyG index is related to the severity of diabetic foot ulcers (DFUs) in patients with type 2 diabetes mellitus (T2DM). METHODS: A total of 1059 T2DM patients were enrolled in this observational, retrospective, single-center study. TyG index was calculated as ln[fasting triglycerides (mg/dl) x fasting glucose (mg/ dl)/2]. The severity of DFUs was classified into mild-to-moderate DFUs (Wagner grade score < 3) and severe DFUs (Wagner grade score >/= 3) based on Wagner classification. Patients were stratified according to the tertiles of TyG index. Logistic regression models were implemented to explore the association between TyG index and the severity of DFUs. Subgroup analyses were used to verify the reliability of results. RESULTS: Compared with the reference lowest TyG tertile (T1), the highest tertile (T3) was associated with 0.377-fold increased risk of prevalence of severe DFUs (odds ratio [OR] 1.377, 95% confidence interval [CI] 1.017-1.865) (P = 0.039). After adjusting for potential confounders, the multivariable-adjusted OR and 95% CI were 1.506 (1.079-2.103) (P = 0.016) in patients with highest tertile. Moreover, subgroup analyses indicated that the association was stronger among men, patients with age >/= 65 years, duration of diabetes more than 10 years, or without PAD. CONCLUSIONS: Elevated TyG index is independently associated with severity of DFUs even after adjusting conventional confounders. CI - (c) 2023. The College of Podiatry and the Australasian Podiatry Council. FAU - Chen, Weihao AU - Chen W AD - Department of Burn and Wound Center, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. FAU - Wang, Xuedong AU - Wang X AD - Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. FAU - Jiang, Qilin AU - Jiang Q AD - Department of Burn and Wound Center, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. FAU - Wu, Jiyan AU - Wu J AD - Department of Burn and Wound Center, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. FAU - Shi, Wanyan AU - Shi W AD - Department of Internal Medicine, Taishun County Hospital of Traditional Chinese Medicine, Wenzhou, Zhejiang, China. FAU - Wang, Xiaoxiao AU - Wang X AD - Department of Endocrine, Wencheng People's Hospital, Wenzhou, Zhejiang, China. FAU - Yin, Yihu AU - Yin Y AD - Department of Burn and Wound Center, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. FAU - Zheng, Jiayin AU - Zheng J AD - Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. FAU - Hu, Xiang AU - Hu X AD - Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. huxiang@wmu.edu.cn. FAU - Lin, Cai AU - Lin C AD - Department of Burn and Wound Center, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. 13025092850@163.com. FAU - Zhang, Xingxing AU - Zhang X AUID- ORCID: 0000-0002-1460-1865 AD - Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Wenzhou, 325000, Zhejiang, China. Zhangxingxing@wzhospital.cn. LA - eng GR - ZJ2021-LD002/Zhejiang Wound Repair and Transformation Application project/ GR - Y2020236/Science and Technology Plan Project of Wenzhou, China/ GR - LGD22H070001/Natural Science Foundation of Zhejiang Province/ PT - Journal Article PT - Observational Study DEP - 20231005 PL - England TA - J Foot Ankle Res JT - Journal of foot and ankle research JID - 101471610 RN - IY9XDZ35W2 (Glucose) RN - 0 (Blood Glucose) RN - 0 (Triglycerides) SB - IM MH - Male MH - Humans MH - Aged MH - Glucose MH - *Diabetes Mellitus, Type 2/complications MH - Risk Factors MH - Retrospective Studies MH - Blood Glucose MH - *Diabetic Foot MH - Triglycerides MH - Reproducibility of Results PMC - PMC10552301 OTO - NOTNLM OT - Chronic wounds OT - Diabetic foot ulcer OT - Triglyceride glucose index COIS- The authors declare that they have no competing interests. EDAT- 2023/10/05 01:00 MHDA- 2023/10/06 06:43 PMCR- 2023/10/05 CRDT- 2023/10/04 23:45 PHST- 2023/04/14 00:00 [received] PHST- 2023/09/04 00:00 [accepted] PHST- 2023/10/06 06:43 [medline] PHST- 2023/10/05 01:00 [pubmed] PHST- 2023/10/04 23:45 [entrez] PHST- 2023/10/05 00:00 [pmc-release] AID - 10.1186/s13047-023-00663-7 [pii] AID - 663 [pii] AID - 10.1186/s13047-023-00663-7 [doi] PST - epublish SO - J Foot Ankle Res. 2023 Oct 5;16(1):68. doi: 10.1186/s13047-023-00663-7.